Actively Recruiting

Phase Not Applicable
Age: 18Years - 110Years
All Genders
Healthy Volunteers
ID07285954

A Randomized Controlled Trial of a Walking Meditation Intervention (iWalk) to Enhance Resilience in Adults

Led by University of Illinois at Urbana-Champaign · Updated on 2025-12-16

90

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the iWalk Program, a walking meditation intervention designed to improve resilience and self-regulation in adults with neurodegenerative diseases such as multiple sclerosis. This randomized controlled trial aims to assess recruitment, retention, adherence, feasibility of assessments, and preliminary psychological and physiological effects. The study will examine changes in resilience, stress, mindfulness, mood, interoceptive awareness, quality of life, and physical activity over time. The iWalk Program lasts 8 weeks and combines mindfulness-based stress reduction with walking meditation. Participants in the active group attend three weekly one-hour sessions, including two virtual and one in-person session focusing on mindfulness, emotional regulation, and positive coping. There are three study groups: one receiving the full iWalk program, one receiving education only without walking meditation, and a waitlist control group receiving usual care during the trial. Participants will be involved for about 10 weeks, including baseline and post-intervention assessments. Evaluations include psychological questionnaires, cognitive tasks, balance tests, and physical activity monitoring using Fitbit and Hexoskin wearable sensors. Electroencephalography (EEG) and group reflections are also part of the assessments. Follow-up assessments occur at 24 and 48 weeks from baseline to measure resilience and cognitive outcomes.

CONDITIONS

Brief Title

Mindfulness Walking Intervention to Enhance Resilience (iWalk)

Who Can Participate

Age: 18Years - 110Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years or older
  • Clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc.
  • No regular meditation practice (e.g., at least 10 minutes per day) and no prior meditation classes or community programs
  • No previous meditation training via coaching, certification, or life coaching
  • Have internet access
  • No severe cognitive impairment (score of 21 21 on Modified Telephonic Interview for Cognitive Status)
  • Able to walk with or without an assistive device (Patient determined Disease Steps score 0-6)
  • Willing to be randomized to an intervention or control group
  • Willing to wear a Fitbit for eight weeks
  • Right-handed according to the Edinburgh Handedness Questionnaire
  • Willing to participate in all assessments, including EEG, cognitive tests, surveys, interviews, or focus groups
  • Willing to wear a Hexoskin t-shirt heart rate monitor during in-person assessments
Not Eligible

You will not qualify if you...

  • Cannot speak, read, write, or listen in English

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 8 weeks

Participants attend the 8-week iWalk Program which includes weekly education, guided walking meditation, and group reflection sessions delivered both in-person and virtually.

3 sessions per week (2 via Zoom, 1 in-person)

Follow-up

Duration - 2 weeks

Participants complete post-intervention assessments including psychological questionnaires, cognitive tasks, and physical activity monitoring to evaluate changes after the program.

1 visit (in-person) and remote assessments

Trial Site Locations

Total: 1 location

1

University of Illinois Urbana-Champaign

Urbana, Illinois, United States, 61801

Actively Recruiting

Loading map...

Research Team

C

Chung-Yi Chiu

V

Vaishnavi Sridharan

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

[18F]NIDF PET Imaging in Tau-related Diseases

Neurodegenerative Disease

Actively Recruiting

2 locations

CP-EXCEL: A Feasibility Randomised Controlled Trial of an On...

Cerebral Palsy

Actively Recruiting

1 location

MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Bl...

Neuromuscular Disease

Actively Recruiting

14 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here